Evaluation of biomarkers in bronchoalveolar lavage fluid for discrimination between asthma and chronic bronchitis in cats

American Journal of Veterinary Research

Volumn 71, Issue 5, 2010, Pages 583-591

  Nafe, Laura A ^a   DeClue, Amy E ^a   Lee Fowler, Tekla M ^a   Eberhardt, Jason M ^a   Reinero, Carol R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 4; NITRIC OXIDE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTHMA; CAT; CHRONIC BRONCHITIS; CONTROLLED STUDY; CYTODIAGNOSIS; EOSINOPHIL COUNT; EXAMINATION; FEMALE; INFLAMMATION; LUNG LAVAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; TUMOR NECROSIS; ANIMAL; ANIMAL DISEASE; BLOOD; BRONCHITIS; CAT DISEASE; CHEMISTRY; CHRONIC DISEASE; CLASSIFICATION; LEUKOCYTE COUNT; METABOLISM; ORCHIECTOMY; OVARIECTOMY; PATHOPHYSIOLOGY;

ANIMALIA;

ANIMALS; ASTHMA; BIOLOGICAL MARKERS; BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; CAT DISEASES; CATS; CHRONIC DISEASE; FEMALE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTE COUNT; MALE; NITRIC OXIDE; ORCHIECTOMY; OVARIECTOMY;

EID: 77953043322     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.5.583     Document Type: Article

References (46)

1. Adamama-Moraitou KK, Patsikas MN, Koutinas AF. Feline lower airway disease: a retrospective study of 22 naturally occurring cases from Greece. J Feline Med Surg 2004;6:227-233.
2. Corcoran BM, Foster DJ, Fuentes VL. Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats. J Small Anim Pract 1995;36:481-488.
3. Foster SF, Allan GS, Martin P, et al. Twenty-five cases of feline bronchial disease (1995-2000). J Feline Med Surg 2004;6:181-188.
4. Moriello KA, Stepien RL, Henik RA, et al. Pilot study: prevalence of positive aeroallergen reactions in 10 cats with small-airway disease without concurrent skin disease. Vet Dermatol 2007;18:94-100.
5. Moise NS, Wiedenkeller D, Yeager AE, et al. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). J Am Vet Med Assoc 1989;194:1467-1473.
6. Norris Reinero CR, Decile KC, Berghaus RD, et al. An experimental model of allergic asthma in cats sensitized to house dust mite or Bermuda grass allergen. Int Arch Allergy Immunol 2004;135:117-131.
7. Prost C. Treatment of feline asthma with allergen avoidance and specific immunotherapy: experience with 20 cats. Rev Fr Allergo! Immunol Clin 2008;48:409-413.
8. Kirschvink N, Leemans J, Delvaux F, et al. Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis. J Feline Med Surg 2006;8:45-54.
9. Brightling C, Berry M, Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol 2008;121:5-10.
10. Jang AS, Choi IS, Lee S, et al. Nitric oxide metabolites in induced sputum: a marker of airway inflammation in asthmatic subjects. Clin Exp Allergy 1999;29:1136-1142. (Pubitemid 29359433)
11. Shahid SK, Kharitonov SA, Wilson NM, et al. Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002;165:1290-1293.
12. Koch M, Witzenrath M, Reuter C, et al. Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation. Am J Respir Cell Mol Biol 2006;35:211-219. (Pubitemid 44175321)
13. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFalpha in pulmonary pathophysiology. Respir Res 2006;7:125.
14. Delen FM, Sippel JM, Osborne ML, et al. Increased exhaled nitric oxide in chronic bronchitis: comparison with asthma and COPD. Chest 2000;117:695-701.
15. Dye JA, McKiernan BC, Rozanski EA, et al. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. J Vet Intern Med 1996;10:385-400.
16. Baarsch MJ, Wannemuehler MJ, Molitor TW, et al. Detection of tumor necrosis factor alpha from porcine alveolar macrophages using an L929 fibroblast bioassay. J Immunol Methods 1991;140:15-22.
17. DeClue AE, Cohn LA, Lechner ES, et al. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. Am J Vet Res 2008;69:228-232.
18. Dargaville PA, South M, Vervaart P, et al. Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999;160:778-784. (Pubitemid 29442008)
19. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8:183-192. (Pubitemid 351323287)
20. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546-3556.
21. Cohn L, Herrick C, Niu N, et al. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J Immunol 2001;166:2760-2767. (Pubitemid 32175128)
22. Reinero CR, Byerly JR, Berghaus RD, et al. Rush immunotherapy in an experimental model of feline allergic asthma. Vet Immunol Immunopathol 2006;110:141-153.
23. Reinero CR, Cohn LA, Delgado C, et al. Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma. Vet Immunol Immunopathol 2008;121:241-250. (Pubitemid 351163398)
24. Larche M. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 2006;18:745-750. (Pubitemid 44635181)
25. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399-408.
26. Brusselle GG, Kips JC, Tavernier JH, et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73-80.
27. Mueller R, Chanez P, Campbell AM, et al. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med 1996;90:79-85. (Pubitemid 26109101)
28. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-1424.
29. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998;50:515-596.
30. Hartl D, Griese M, Nicolai T, et al. Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. J Allergy Clin Immunol 2005;115:728-736. (Pubitemid 40460846)
31. Wong CK, Ho CY, Ko FW, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001;125:177-183.
32. Marguet C, Dean TP, Warner JO. Soluble intercellular adhesion molecule-1 (sICAM-1) and interferon-gamma in bronchoalveolar lavage fluid from children with airway diseases. Am J Respir Crit Care Med 2000;162:1016-1022.
33. Kumar RK, Webb DC, Herbert C, et al. Interferon-gamma as a possible target in chronic asthma. Inflamm Allergy Drug Targets 2006;5:253-256. (Pubitemid 44941936)
34. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-534. (Pubitemid 126423950)
35. Katsuki M. Neutrophil chemotactic activity in bronchoalveolar lavage fluid recovered from patients with diffuse panbronchiolitis. Kurume Med J 1996;43:279-287. (Pubitemid 27062774)
36. Dweik RA, Comhair SA, Gaston B, et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A 2001;98:2622-2627. (Pubitemid 32209532)
37. van der Vliet A, Eiserich JP, Shigenaga MK, et al. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 1999;160:1-9.
38. Kumar L, Rajput N, Majumdar S. Nitric oxide metabolites in induced sputum: a noninvasive marker of airway inflammation in asthma. Indian Pediatr 2005;42:329-337. (Pubitemid 40663690)
39. Payne DN. Nitric oxide in allergic airway inflammation. Curr Opin Allergy Clin Immunol 2003;3:133-137. (Pubitemid 36529504)
40. Kharitonov SA, Barnes PJ. Nitric oxide in exhaled air is a new marker of airway inflammation. Monaldi Arch Chest Dis 1996;51:533-537. (Pubitemid 27076048)
41. Liu MC, Proud D, Lichtenstein LM, et al. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol 2001;108:29-38. (Pubitemid 32662229)
42. Reinero CR, Brownlee L, Decile KC, et al. Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis, but has minimal systemic immune effects in healthy cats. J Vet Intern Med 2006;20:57-64. (Pubitemid 43219374)
43. Herbert C, Hettiaratchi A, Webb DC, et al. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Clin Exp Allergy 2008;38:847-856. (Pubitemid 351550666)
44. Hawkins EC, DeNicola DB, Kuehn NF. Bronchoalveolar lavage in the evaluation of pulmonary disease in the dog and cat. State of the art. J Vet Intern Med 1990;4:267-274.
45. Jatakanon A, Uasuf C, Maziak W, et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-1539.
46. Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 2000;30(suppl 1):22-27.